The Cooper Companies, Inc.
NASDAQ:COOMedical - Instruments & Supplies
-$2.30 today
- Market cap
- $11.55B
- Beta
- 0.87
- P/E (TTM)
- 53.8
- EPS (TTM)
- $1.21
Volume 2.20M
Average 2.55M
COO EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
The Cooper Companies, Inc.NASDAQ: COO
EPS (Diluted) · Q3 FY2026 · quarter ended Jul 2026
EPS (Diluted) growth accelerates
Q3 FY2026 EPS (Diluted) of $2.24 rose 357.1% year over year, ahead of the +44.3% change in trailing-twelve-month EPS (Diluted). Over 3 fiscal years it compounded at -1.2% a year.
Context
- EPS (Diluted) increased in 1 of the last 3 fiscal years.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 11 analysts of $4.53 (+142.3%) for the fiscal year ending Oct 2026, a step up from the -4.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJul 2026
- $2.24+660.0% QoQ
- Last fiscal yearOct 2025
- $1.87-4.6% YoY
- LTMJul 2026
- $2.93+44.3% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 1.87 USD
- Year-over-year change
- -4.6%
- 4-year CAGR
- -40.4%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-10-31 | 1.87 | -4.6% |
| FY2024 | 2024-10-31 | 1.96 | +32.4% |
| FY2023 | 2023-10-31 | 1.48 | -23.7% |
| FY2022 | 2022-10-31 | 1.94 | -86.9% |
| FY2021 | 2021-10-31 | 14.79 | — |
EPS (Diluted) vs competitors
How COO compares with its peers on the latest reported figures
- COO's LTM Jul 2026 EPS (Diluted) of $2.93 is the highest of the 6 companies compared; the peer median is -$0.48.
- Its year-over-year change of +44.3% is the 3rd highest of 6, against a peer median of +38.5%.
- Over three fiscal years its annual growth of -1.2% compares with a peer median of +42.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jul 2026 | $2.93 | +44.3% | -1.2% | |
| LTM Sep 2026 | $1.36 | -35.2% | +42.8% | |
| LTM Apr 2026 | -$0.42 | +70.8% | — | |
| LTM Jun 2026 | -$0.48 | +38.5% | — | |
| LTM Mar 2026 | -$0.58 | +88.1% | — | |
| LTM Jun 2026 | -$3.25 | -97.0% | — | |
| Peer median (excluding COO) | -$0.48 | +38.5% | +42.8% | |
Competitors are the stored peer set for COO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Oct 2021 | FY2022 Oct 2022 | FY2023 Oct 2023 | FY2024 Oct 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Revenue | 2.92B | 3.31B | 3.59B | 3.9B | 4.09B |
| Cost of Revenue | 966.7M | 1.17B | 1.24B | 1.3B | 1.61B |
| Gross Profit | 1.96B | 2.14B | 2.36B | 2.6B | 2.48B |
| Gross Margin | 66.9% | 64.7% | 65.6% | 66.6% | 60.7% |
| Research & Development | 92.7M | 110.3M | 137.4M | 155.1M | 172.2M |
| Selling, General & Admin | 1.21B | 1.34B | 1.5B | 1.53B | 1.63B |
| Operating Expenses | 1.45B | 1.63B | 1.82B | 1.89B | 1.8B |
| Depreciation & Amortization | 309.3M | 346.1M | 367.7M | 375.1M | 423M |
| EBITDA | 823.9M | 878.7M | 885.9M | 1.07B | 1.05B |
| EBITDA Margin | 28.2% | 26.6% | 24.7% | 27.5% | 25.7% |
| Operating Income | 505.8M | 507.6M | 533.1M | 705.7M | 682.9M |
| Operating Margin | 17.3% | 15.3% | 14.8% | 18.1% | 16.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 23.1M | 57.3M | 105.3M | 114.3M | 100M |
| Other Income / Expenses | (14.3M) | (32.3M) | (120.2M) | (123.4M) | (116.4M) |
| Income Before Tax | 491.5M | 475.3M | 412.9M | 582.3M | 566.5M |
| Pre-Tax Margin | 16.8% | 14.4% | 11.5% | 14.9% | 13.8% |
| Income Tax Expense | (2.45B) | 89.5M | 118.7M | 190M | 191.6M |
| Net Income | 2.94B | 385.8M | 294.2M | 392.3M | 374.9M |
| Net Margin | 100.8% | 11.7% | 8.2% | 10.1% | 9.2% |
| EPS (Basic) | 14.93 | 1.96 | 1.49 | 1.97 | 1.88 |
| EPS (Diluted) | 14.79 | 1.94 | 1.48 | 1.96 | 1.87 |
| Weighted Avg Shares | 197.2M | 197.2M | 198M | 198.9M | 200M |
| Weighted Avg Shares (Diluted) | 199.4M | 198.8M | 199.2M | 200.4M | 200M |
The Cooper Companies, Inc.
NASDAQ:COO
Intrinsic Alpha fair value
Locked
Current Price
$60.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.